Latest Uk Market News

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

AML3D Limited surged to a record $12.5 million revenue in FY26, delivering its first half-year EBITDA profit and locking in a $29 million order book driven by US Defence contracts and UK market entry.

IODM Limited’s FY26 results show solid revenue gains led by UK education, but losses persist with a net deficiency in equity raising going concern questions.

The Koala Company posted a $24.6 million profit for FY26 on $332.3 million revenue, surpassing IPO forecasts with strong international growth and margin gains.

Control Bionics has secured MHRA registration for its NeuroStrip device, unlocking commercial supply in Great Britain and launching early trials with leading UK institutions.

Janison Education Group posted a 3% revenue rise to $48.1 million in FY26, underpinned by international contract expansion and AI innovation, despite margin pressure from onboarding costs.

Skellerup Holdings delivered a tenth consecutive year of EBIT growth with a 14% rise to NZD 89.3 million and expanded its climate initiatives, reporting a 24% jump in net profit to NZD 67.7 million.

Doctor Care Anywhere delivered a 27% rise in EBITDA and doubled free cash flow in H1 2026, driven by operational efficiencies and a strategic entry into the UK weight management market via acquisition.

Premier Investments trims FY26 Premier Retail EBIT forecast to $176 million, citing tough trading conditions and announces exit from UK Peter Alexander stores while focusing on Australian growth and loyalty programs.

Kelly Partners Group Holdings boosted FY26 revenue by 18.2% to $159.2 million, underpinned by six acquisitions including a key US CPA firm. Underlying NPATA rose 18.9% to $10.8 million, while the group deepened its global footprint across five countries.

Corporate Travel Management (ASX:CTD) has extended its exclusive contract with the UK Ministry of Defence to provide accommodation services for the Afghan Resettlement Programme, with expected transaction values reaching £28 million in the first six months.

Rua Bioscience has approved a $600,000 convertible note facility aimed at boosting inventory purchases to accelerate its UK market expansion following a major distribution deal.